Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CIMZIA
- A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)
- Zr-89 Cimzia PET Imaging Rheumatoid Arthritis
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately t
- A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis
- IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
- A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis
- A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU
- Lipids, Inflammation, and CV Risk in RA
- Does Clinical Response Correlate With Serum Certolizumab Levels?
- Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis
- Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity
- IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
- Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept
- An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044
- Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis
- A Study of Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid Arthritis
- Prediction of Response to Certolizumab Pegol Treatment by Functional MRI of the Brain
- Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease
- Novel Imaging Markers for Rheumatoid Arthritis
- Cimzia Versus Mesalamine for Crohn's Recurrence
- Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis
- Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis
- EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment
- Pediatric Arthritis Study of Certolizumab Pegol
- RHYTHM (Formerly Escape II Myocardium)
- Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
- Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction
- Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)
- The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients
- Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis
- Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia
- Study of Cimzia for the Treatment of Ulcerative Colitis
- Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy
- A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis
- The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents
- Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients
- Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients
- SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
- A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy
- Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)
- Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis
- Dosing Flexibility Study in Patients With Rheumatoid Arthritis
- Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis
- Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy
Clinical trials list
click for details